Seshadri Vishwas 4

What Happened

Seshadri Vishwas, CEO of Abeona Therapeutics (ABEO), sold 69,832 shares on January 22, 2026 in open-market transactions. The weighted-average price was $5.33 (trades ranged $5.33–$5.38), generating proceeds of approximately $372,267. The filing notes the sale was made to cover tax obligations associated with the vesting of restricted stock awards (footnote F1).

Key Details

• Transaction date: 2026-01-22
• Transaction type: Sale (open-market), Form 4 reported (code S)
• Shares sold: 69,832
• Price: weighted average $5.33; trades ranged $5.33–$5.38 (footnote F2)
• Proceeds: ~$372,267
• Reason reported: Tax withholding on vested restricted stock awards (footnote F1)
• Shares owned after transaction: Not specified in the provided excerpt (see full Form 4 for beneficial ownership)
• Filing timeliness: Report filed on 2026-01-22 (same day as the reported transaction date)

Context

This was a tax-withholding sale tied to vested restricted stock—common for executives when awards vest and taxes are due. Such sales are typically routine and do not necessarily indicate a change in the insider’s view of the company. Retail investors may want to monitor future insider buys/sells and company fundamentals for more meaningful signals.